C-peptide determination as a parameter for oral diabetes therapy
Beischer, W.; Raptis, S.; Keller, L.; Kerner, W.; Pfeiffer, E.F.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 791-794
1976
ISSN/ISBN: 0070-4067 PMID: 829388 Document Number: 100095
Document emailed within 1 workday
Related Documents
Halaby, G.; Karam, J.; Jambart, S.; Aydenian, H.; Zankoul, R.; Gannagé, M.H. 1989: Importance of peptide C determination in diabetes Le Journal Medical Libanais. Lebanese Medical Journal 38(1): 29-34Horstkotte, D.; Bergemann, R.; Oelert, H.; Schulte, H.D.; Laas, J.; Zerkowski, H.R. 1998: Increased acceptance of the International Normalized Ratio (INR) as a monitoring parameter of oral anticoagulation therapy in Germany. GELIA Study Group Zeitschrift für Kardiologie 87(10): 837-843
Teuscher, A. 1972: Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged Schweizerische Medizinische Wochenschrift 102(24): 848-855
Shubrook, J.H. 2018: Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy Journal of Family Practice 67(8 Suppl): S49-S54
Bruneder, H. 1985: Possibilities and limits of oral diabetes therapy Wiener Medizinische Wochenschrift 135(6-7): 147-151
Bergis, K.; Heilmann, B. 1987: Secondary failure of oral diabetes therapy Fortschritte der Medizin 105(4): 64-68
Kazeĭ, N.S.; Granovskaia-Tsvetkova, A.M. 1992: Oral therapy of patients with type Ii diabetes mellitus Problemy Endokrinologii 38(2): 46-48
Shimokawa, H.; Sumioki, H.; Miyamoto, S.; Maeda, H.; Yamaguchi, Y.; Nakano, H. 1988: Is human atrial natriuretic peptide in fetal blood useful as a parameter to detect the decompensate state of the fetal heart? Journal of Perinatal Medicine 16(5-6): 485-486
Grujić, M.; Perinović, M.; Rizvanbegović, B. 1976: Oral therapy of diabetes mellitus by combination of hypoglycemic agents Medicinski Arhiv 30(3): 167-171
Gomo, Z. 1992: Serum fructosamine: a parameter for monitoring metabolic control in diabetes Central African Journal of Medicine 38(9): 358-362
Parakh, M.Kumar.; Kasi, A.; Ayyappan, V.; Subramani, P. 2020: Knowledge and Awareness of Oral Manifestations of Diabetes Mellitus and Oral Health Assessment among Diabetes Mellitus Patients- A Cross Sectional Study Current Diabetes Reviews 16(2): 156-164
Düntsch, G. 1970: Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions Arzneimittel-Forschung 20(4): 575-579
Kitamura, K.; Arai, K.; Futamata, H.; Sakamuro, M.; Hashimoto, T.; Matsubara, F.; Yonezawa, K.; Baba, H. 1988: Study of the new useful electrophysiological parameter in diagnosing carpal tunnel syndrome associated with diabetes mellitus Rinsho Byori. Japanese Journal of Clinical Pathology 36(11): 1335-1339
Bounameaux, H.; Duckert, F.; Walter, M.; Bounameaux, Y. 1978: The determination of antithrombin III. Comparison of six methods. Effect of oral contraceptive therapy Thrombosis and Haemostasis 39(3): 607-615
Venter, H.L.; Joubert, P.H.; Foukaridis, G.N. 1991: Compliance in black patients with non-insulin-dependent diabetes mellitus receiving oral hypoglycaemic therapy South African Medical Journal 79(9): 549-551
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Dorn, D.; Fuchs, C.; Henning, H.V.; Leititis, J.; McIntosh, C.; Scheler, F. 1975: Fluoride determination in the serum--a new additional parameter for bone metabolism in patients with chronic kidney failure Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 974-975
Zhurova, M.V.; Vediaeva, L.V. 1980: Determination of total and separate blood levels of nucleic acids (RNA and DNA) in states of diverse severity of diabetes mellitus and during antidiabetic therapy Terapevticheskii Arkhiv 52(8): 73-77
Tani, M.; Yamaue, H. 2012: Multidisciplinary therapy for pancreatic cancer - clinical impact for preoperative therapy and peptide vaccine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 364-367
Ishibashi, Y.; Aoki, H.; Ohba, J.; Kamikubo, Y.; Morimoto, K.; Kumasaka, A. 1996: PT-INR as a parameter for anticoagulant therapy after valve replacement surgery Kyobu Geka. Japanese Journal of Thoracic Surgery 49(11): 906-908